BIL Vyapar Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 22, 2025, 8:18 am

Competitors of BIL Vyapar Ltd

All Competitor Stocks of BIL Vyapar Ltd

Quarterly Result

Last Updated: September 5, 2025, 2:59 pm

Below is a detailed analysis of the quarterly data for BIL Vyapar Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Expenses, as of Jun 2025, the value is 0.70 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.42 Cr. (Mar 2025) to 0.70 Cr., marking an increase of 0.28 Cr..
• For Operating Profit, as of Jun 2025, the value is -0.70 Cr.. The value appears to be declining and may need further review. It has decreased from -0.42 Cr. (Mar 2025) to -0.70 Cr., marking a decrease of 0.28 Cr..
• For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.02 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -0.70 Cr.. The value appears to be declining and may need further review. It has decreased from -0.40 Cr. (Mar 2025) to -0.70 Cr., marking a decrease of 0.30 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is -0.70 Cr.. The value appears to be declining and may need further review. It has decreased from -0.40 Cr. (Mar 2025) to -0.70 Cr., marking a decrease of 0.30 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.22. The value appears to be declining and may need further review. It has decreased from -0.13 (Mar 2025) to -0.22, marking a decrease of 0.09.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:45 am

Balance Sheet

Last Updated: September 5, 2025, 2:59 pm

Below is a detailed analysis of the balance sheet data for BIL Vyapar Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 31.38 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 31.38 Cr..
• For Reserves, as of Mar 2025, the value is -217.63 Cr.. The value appears to be improving (becoming less negative). It has improved from -224.46 Cr. (Mar 2024) to -217.63 Cr., marking an improvement of 6.83 Cr..
• For Borrowings, as of Mar 2025, the value is 173.46 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 172.03 Cr. (Mar 2024) to 173.46 Cr., marking an increase of 1.43 Cr..
• For Other Liabilities, as of Mar 2025, the value is 28.10 Cr.. The value appears to be improving (decreasing). It has decreased from 36.79 Cr. (Mar 2024) to 28.10 Cr., marking a decrease of 8.69 Cr..
• For Total Liabilities, as of Mar 2025, the value is 15.31 Cr.. The value appears to be improving (decreasing). It has decreased from 15.74 Cr. (Mar 2024) to 15.31 Cr., marking a decrease of 0.43 Cr..
• For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 15.31 Cr.. The value appears to be declining and may need further review. It has decreased from 15.74 Cr. (Mar 2024) to 15.31 Cr., marking a decrease of 0.43 Cr..
• For Total Assets, as of Mar 2025, the value is 15.31 Cr.. The value appears to be declining and may need further review. It has decreased from 15.74 Cr. (Mar 2024) to 15.31 Cr., marking a decrease of 0.43 Cr..

However, the Borrowings (173.46 Cr.) are higher than the Reserves (-217.63 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for BIL Vyapar Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.18. This value is below the healthy minimum of 5. It has increased from -2.28 (Mar 24) to 2.18, marking an increase of 4.46.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.18. This value is below the healthy minimum of 5. It has increased from -2.28 (Mar 24) to 2.18, marking an increase of 4.46.
• For Cash EPS (Rs.), as of Mar 25, the value is 2.17. This value is below the healthy minimum of 3. It has increased from -2.28 (Mar 24) to 2.17, marking an increase of 4.45.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -59.34. It has increased from -61.52 (Mar 24) to -59.34, marking an increase of 2.18.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -59.34. It has increased from -61.52 (Mar 24) to -59.34, marking an increase of 2.18.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -0.59. This value is below the healthy minimum of 2. It has increased from -2.28 (Mar 24) to -0.59, marking an increase of 1.69.
• For PBIT / Share (Rs.), as of Mar 25, the value is -0.59. This value is below the healthy minimum of 0. It has increased from -2.28 (Mar 24) to -0.59, marking an increase of 1.69.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.17. This value is within the healthy range. It has increased from -2.28 (Mar 24) to 2.17, marking an increase of 4.45.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.17. This value is within the healthy range. It has increased from -2.28 (Mar 24) to 2.17, marking an increase of 4.45.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.17. This value is within the healthy range. It has increased from -2.28 (Mar 24) to 2.17, marking an increase of 4.45.
• For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 8. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Return on Networth / Equity (%), as of Mar 25, the value is -3.66. This value is below the healthy minimum of 15. It has decreased from 0.00 (Mar 24) to -3.66, marking a decrease of 3.66.
• For Return on Capital Employeed (%), as of Mar 25, the value is 1.00. This value is below the healthy minimum of 10. It has decreased from 3.70 (Mar 24) to 1.00, marking a decrease of 2.70.
• For Return On Assets (%), as of Mar 25, the value is 44.61. This value is within the healthy range. It has increased from -45.42 (Mar 24) to 44.61, marking an increase of 90.03.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is -0.93. This value is within the healthy range. It has decreased from -0.89 (Mar 24) to -0.93, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Current Ratio (X), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 1.5. There is no change compared to the previous period (Mar 24) which recorded 0.07.
• For Quick Ratio (X), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.07.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Enterprise Value (Cr.), as of Mar 25, the value is 204.99. It has decreased from 215.55 (Mar 24) to 204.99, marking a decrease of 10.56.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For EV / EBITDA (X), as of Mar 25, the value is -109.76. This value is below the healthy minimum of 5. It has decreased from -30.16 (Mar 24) to -109.76, marking a decrease of 79.60.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is -0.17. This value is below the healthy minimum of 1. It has increased from -0.22 (Mar 24) to -0.17, marking an increase of 0.05.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For EarningsYield, as of Mar 25, the value is 0.21. This value is below the healthy minimum of 5. It has increased from -0.16 (Mar 24) to 0.21, marking an increase of 0.37.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness